|Bid||40.32 x 800|
|Ask||40.33 x 900|
|Day's range||38.35 - 40.64|
|52-week range||27.38 - 156.82|
|Beta (5Y monthly)||0.81|
|PE ratio (TTM)||N/A|
|Earnings date||25 Oct 2022 - 31 Oct 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||36.89|
Teladoc shares are trading higher after D.A. Davidson initiated coverage of the virtual health care company and $45 price target.
Teladoc stock has fallen 88% since peaking last year. There are still investors that feel the time is right to buy or add to a position.